The following is a statement released June 17 by Biomedical Advanced Research and Development Authority Director and Deputy Assistant Secretary for Preparedness and Response, Robin Robinson, PhD.  This week, our nation reached a milestone in battling influenza, with the U.S. Food and Drug Administration’s first approval to manufacture ...